Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
Askling J, van Vollenhoven RF, Granath F, Raaschou P, Fored CM, Baecklund E, Dackhammar C, Feltelius N, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Rantapää-Dahlqvist S, Saxne T, Klareskog L. Askling J, et al. Among authors: dackhammar c. Arthritis Rheum. 2009 Nov;60(11):3180-9. doi: 10.1002/art.24941. Arthritis Rheum. 2009. PMID: 19877027 Free article.
Ten years with biologics: to whom do data on effectiveness and safety apply?
Simard JF, Arkema EV, Sundström A, Geborek P, Saxne T, Baecklund E, Coster L, Dackhammar C, Jacobsson L, Feltelius N, Lindblad S, Rantapää-Dahlqvist S, Klareskog L, van Vollenhoven RF, Neovius M, Askling J. Simard JF, et al. Among authors: dackhammar c. Rheumatology (Oxford). 2011 Jan;50(1):204-13. doi: 10.1093/rheumatology/keq326. Epub 2010 Nov 16. Rheumatology (Oxford). 2011. PMID: 21084326
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
van Vollenhoven RF, Ernestam S, Geborek P, Petersson IF, Cöster L, Waltbrand E, Zickert A, Theander J, Thörner A, Hellström H, Teleman A, Dackhammar C, Akre F, Forslind K, Ljung L, Oding R, Chatzidionysiou A, Wörnert M, Bratt J. van Vollenhoven RF, et al. Among authors: dackhammar c. Lancet. 2009 Aug 8;374(9688):459-66. doi: 10.1016/S0140-6736(09)60944-2. Lancet. 2009. PMID: 19665644 Clinical Trial.
Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial.
van Vollenhoven RF, Geborek P, Forslind K, Albertsson K, Ernestam S, Petersson IF, Chatzidionysiou K, Bratt J; Swefot study group. van Vollenhoven RF, et al. Lancet. 2012 May 5;379(9827):1712-20. doi: 10.1016/S0140-6736(12)60027-0. Epub 2012 Mar 29. Lancet. 2012. PMID: 22464340 Clinical Trial.
Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice.
Neovius M, Simard JF, Klareskog L, Askling J; ARTIS Study Group. Neovius M, et al. Ann Rheum Dis. 2011 Aug;70(8):1407-14. doi: 10.1136/ard.2010.144139. Epub 2011 Apr 25. Ann Rheum Dis. 2011. PMID: 21518724
How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop?
Neovius M, Simard JF, Askling J; ARTIS Study Group. Neovius M, et al. Ann Rheum Dis. 2011 Jun;70(6):1010-5. doi: 10.1136/ard.2010.136812. Epub 2011 Mar 15. Ann Rheum Dis. 2011. PMID: 21406455
Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents.
Raaschou P, Simard JF, Neovius M, Askling J; Anti-Rheumatic Therapy in Sweden Study Group. Raaschou P, et al. Arthritis Rheum. 2011 Jul;63(7):1812-22. doi: 10.1002/art.30247. Arthritis Rheum. 2011. PMID: 21305513 Free article.
Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial.
Saevarsdottir S, Wallin H, Seddighzadeh M, Ernestam S, Geborek P, Petersson IF, Bratt J, van Vollenhoven RF; SWEFOT Trial Investigators Group. Saevarsdottir S, et al. Ann Rheum Dis. 2011 Mar;70(3):469-75. doi: 10.1136/ard.2010.139212. Epub 2010 Dec 13. Ann Rheum Dis. 2011. PMID: 21149498 Clinical Trial.
Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden.
Neovius M, Simard JF, Askling J; ARTIS study group. Neovius M, et al. Ann Rheum Dis. 2011 Apr;70(4):624-9. doi: 10.1136/ard.2010.133371. Epub 2010 Dec 13. Ann Rheum Dis. 2011. PMID: 21149495
Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009.
Neovius M, Sundström A, Simard J, Wettermark B, Cars T, Feltelius N, Askling J, Klareskog L; ARTIS Study Group. Neovius M, et al. Scand J Rheumatol. 2011 Jan;40(1):8-15. doi: 10.3109/03009742.2010.493895. Epub 2010 Oct 18. Scand J Rheumatol. 2011. PMID: 20955087